Name Address/P.O. Box Postal Code/City Country Contact Person Telephone Email Website Social Media Number of Employees Founded (year) Type of Laboratory Areas of Activity
›
Excelya
›
738 rue Yves Kermen 92100 Boulogne Billancourt France Alan Morgan +33-1-46-20-74-50 contact@excelya.com www.excelya.com
›
I
› › › › › ›
› › ›
›
900+ 2014 CRO Clinical Operations, Data Management, eTMF, Medical Writing & Publishing, Medical Affairs & Monitoring, Pharmacovigilance & Safety, Quality Assurance, Regulatory Affairs, Statistics & Programming, Strategic Development & Governance, Vendor Management & Oversight
Excelya is a premium independent CRO headquartered in Europe, providing support to clients around the globe in the pharmaceutical, medical device, and biotechnology industries. With a strong desire to add value and to deliver expertise to both clients and employees alike, Excelya strives to become an integrated part of sponsor teams and projects. By delivering long-term career development to staff, we are able to provide clients with contractors who are dedicated and are rich in expertise and experience. With 900+ staff, decades of therapeutic experience, and global capabilities across 25+ countries, we are bringing a fresh approach to clinical trials. Full service. FSP. Consulting. To meet your needs, we leverage 30 years of local, therapeutic, and service experience. Our focus is on your project, for which we utilise our expertise, experience, and technology. Our aim is to expertly recruit the right personnel and implement the right processes to help our clients meet their objectives. Not only do we have an impressive existing network of employees across Europe, India, and beyond, but we regularly attract and onboard highquality candidates. We believe that our people are our greatest assets, and have an internal team dedicated to sourcing, recruiting, and nurturing our best-in-class team members. Not only does Excelya supply quality people to execute your clinical trials and R&D operations, we also have a uniquely scalable model where clients receive a tailored SLA that will deliver the results needed, in a way that satisfies a plethora of budgets, geographies, trial phases, therapeutic areas, and more.
